2026-01-22 - Analysis Report
# Merck Analysis Report

### Company Overview
Merck is a multinational pharmaceutical company that develops, manufactures, and markets a range of pharmaceutical, biopharmaceutical, and animal healthcare products.

### Comparison of Stock Return Rates

| Ticker | Cumulative Return |
| --- | --- |
| MRK (Merck) | 28.30% |
| VOO (S&P 500) | 91.55% |
| Divergence (max: 25.90, min: -97.40, current: -67.60) | -67.60 |

The cumulative return of Merck stock is lower than that of the S&P 500, indicating a lower investment return.

### Alpha, Beta Analysis

| Period | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 24.0% | 14.7% | 20.0% | 0.7 | 182.1B |
| 2017-2019 | 37.0% | 14.7% | 19.0% | 0.7 | 216.8B |
| 2018-2020 | 13.0% | 19.3% | -8.0% | 0.7 | 195.0B |
| 2019-2021 | 0.0% | 19.3% | -43.0% | 0.6 | 191.4B |
| 2020-2022 | 14.0% | 16.3% | 16.0% | 0.5 | 277.1B |
| 2021-2023 | 31.0% | 14.3% | 30.0% | 0.3 | 272.3B |
| 2022-2024 | -5.0% | 24.9% | -24.0% | 0.3 | 248.5B |
| 2023-2025 | -24.0% | 39.0% | -86.0% | 0.3 | 262.9B |

The CAGR (Compound Annual Growth Rate) for some periods is lower, while the MDD (Maximum Drawdown) is higher, indicating that Merck's stock price has been more volatile.

### Recent Stock Price Fluctuations

| Metric | Value |
| --- | --- |
| Close | $111.11 |
| Last-market Price | $109.45 |
| Change | $1.52 |
| 5-day SMA | $110.27 |
| 20-day SMA | $108.13 |
| 60-day SMA | $99.21 |

Merck's stock price has experienced a recent upswing, with the 5-day SMA showing a slight increase.

### RSI, PPO Index Indicators

| Indicator | Value |
| --- | --- |
| RSI | 64.84 |
| PPO | -0.22 |
| Hybrid Signal | Buy (Cash 0%) |
| Risk Level | Medium (MRI 0.80) |
| Recent Relative Divergence Change | -1.00 (worsening) |
| 7-day Rank Change | 35 (+) |
| 7-day Dynamic Expected Return Change | -2.90 (-) |

The RSI and PPO indicators suggest a mixed signal, with the hybrid signal indicating a buy signal. However, the recent relative divergence change is worsening.

### Expected Return
Expected Return (%) = -29.60%, Expected excess return compared to S&P 500 if invested long-term (more than 2 years) from this point.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.